Clinical Trial Update: IST Neoadjuvant Abraxane in Newly Diagnosed Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating neoadjuvant Abraxane (nab-paclitaxel) in newly diagnosed breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)

Snippet

Sponsor: Barwon Health | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN